Orphan Drugs Research and Commercialization Conference

 GTC is proud to announce its inaugural Orphan Drugs Research and Commercialization Conference at a crucial time in the rare disease space. With new therapies emerging in rare disease treatment and exciting partnerships being forged between big pharma and smaller niche companies, it is clear that the field of rare disease and orphan drug is growing. Rather than merely reciting the challenges of orphan drug development, it is time all stakeholders in the community come together to find innovative solutions in order to better serve rare disease patients.

This meeting connects industry, academia, regulators, and patient groups to dialogue about strategies to improve orphan drug research, pricing, reimbursement, access, and other key topics. 

The Orphan Drugs Research and Commercialization Conference is one of four parallel tracks to the 2nd Novel Technologies in Drug Discovery Summit on May 8 - 10,  2013 in Boston, MA. 

Tentative Sessions Include:

Pre-Conference Workshop: Developing an Effective Pricing and Reimbursement Strategy
Novel Therapeutics in Rare Diseases
Designing Effective Clinical Trials Case Studies in the Preclinical and Clinical Space
Partnering in Rare Diseases
Commercialization of Orphan Drugs
Panel Discussion: Regulatory in Orphan Drug Development